Finance's Graham-Cassidy Hearing Doesn’t Clarify Bill’s Effect On Pre-Existing Condition Coverage

September 25, 2017 at 10:03 PM
GOP defenses of the Graham-Cassidy bill’s impact on the individual market premiums during a Senate Finance Committee hearing Monday (Sept. 25) focused on what Sen. Bill Cassidy (R-LA) called a statutory version of an 1115-1332 superwaiver, which essentially blends the Medicaid expansion and individual market pools. All federal funding would be distributed based on complex formulas via block grant. Republicans made their argument Monday at the sole hearing on the legislation, held just after the latest version of the bill...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.